Genetics Research, LLC (“GR”), a privately-held company developing a portfolio of novel and proprietary CRISPR-associated technologies for targeted DNA enrichment, announced today that it has licensed certain of its patents relating to this technology to Oxford Nanopore Technologies, Ltd. (“Oxford Nanopore”) based in Oxford, United Kingdom. This license enables Oxford Nanopore to use GR patents […]
COLUMBIA, Md. — Through the Shimadzu Partnership for Academics, Research and Quality of Life (SPARQ) program, Shimadzu Scientific Instruments and Walsh University have collaborated to enhance the school’s science division. Shimadzu and Walsh University began their partnership in January and have successfully completed the installation of nearly $1.2 million worth of new analytical equipment into […]
JEOL and Advanced Chemistry Development, Inc. (ACD/Labs) announced they have concluded a distribution agreement for ACD/NMR software. NMR Predictor Suite having a structure predictive function is the software which can predict an NMR spectrum from chemical structure information, among ACD/NMR software. It is the tool which can perform structure analysis easily. For a user who is […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and QIAGEN N.V. today announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products. The agreement grants QIAGEN a non-exclusive development license to Bio-Techne’s exosome technology for the development […]
CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies Principal Focus on Advancing Understanding of Breast and Skin Cancer Risks SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced its participation in CANCERPREV, a research […]
New AI leverages high quality, experimental reactions featured in Reaxys’ chemistry database, will allow chemists to increase the success rate of synthetic chemistry New York — Elsevier, a global research publishing and information analytics provider, is collaborating with Pending.AI (PAI), a start-up focused on developing artificial intelligence (AI) solutions for drug discovery, to develop the predictive retrosynthesis […]
DUBLIN, Ireland, and Milpitas, CA USA: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents. ERS Genomics holds […]
Phasefocus is pleased to announce the continuation of its global extension programme with the appointment of ParalabBio as representation in Portugal and Spain. This market expansion is in response to growing interest in Livecyte™, the company’s flagship cell imaging and analysis platform which enables users to uncover differences in cell behaviour that previously have been […]
Phasefocus is pleased to announce the continuation of its global extension programme with the appointment of ParalabBio as representation in Portugal and Spain. This market expansion is in response to growing interest in Livecyte™, the company’s flagship cell imaging and analysis platform which enables users to uncover differences in cell behaviour that previously have been […]
MELBOURNE, Australia — Illumina (NASDAQ: ILMN) announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and track COVID-19 using genomics across the country, rather than state by state, under a ground-breaking initiative spearheaded by Australia’s public health laboratory organisations and leading industry […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
